Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment (EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?-Reference-Cited by-同舟云学术

Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment (EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?

Published:2020-09 Issue:9 Volume:124 Page:943-951
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Chassagnol F,Marcelli G,Wagle J,Giuliani G,Traub D,Schaub V,Ruof J

Funder

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Health Policy

Reference27 articles.

1. Heterogeneity in relative efficacy assessments (REA) across european HTA bodies: opportunity for improving efficiency and speed of access to patients?;Jain;Value Health,2015

2. https://www.eunethta.eu/rapid-reas/8 (accessed Jan 3rd, 2020).

3. https://www.eunethta.eu/services/early-dialogues/8 (accessed Jan 3rd, 2020).

4. Leveraging EUnetHTA’s conceptual framework to compare decision drivers in France, Italy, and Germany from a manufacturer’s point of view;Giuliani;Health Econ Rev,2018

5. Is the EUnetHTA Core® Model fit for purpose? Evaluation from an Industry Perspective;Gyldmark;Int J Technol Assess Health Care,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy;Health Research Policy and Systems;2024-07-02

2. Guiding Principles for Evaluating Vaccines in Joint Health Technology Assessment in the European Union: Preparing for the European Union’s Regulation on Health Technology Assessment for Vaccines;Value in Health;2024-07

3. Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations;Clinical Pharmacology & Therapeutics;2024-03-20

4. Stakeholder perspectives on cooperation in the clinical and nonclinical health technology assessment domains;International Journal of Technology Assessment in Health Care;2023

5. Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European Access Academy;Health Economics Review;2022-11-05